Treatment of four psychiatric emergencies in the intensive care unit

Critical Care Medicine

Volumn 40, Issue 9, 2012, Pages 2662-2670

  Joseph Bienvenu, O ^a,b   Neufeld, Karin J ^a   Needham, Dale M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

delirium; depression; dexmedetomidine; intensive care units; mental disorders; neuroleptic malignant syndrome; overdose; posttraumatic stress disorder; serotonin syndrome

Indexed keywords

4 AMINOBUTYRIC ACID; AMITRIPTYLINE; BENZODIAZEPINE; BROMOCRIPTINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DANTROLENE; DEXMEDETOMIDINE; DICYCLOVERINE; DIPHENHYDRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOXEPIN; DROPERIDOL; FLUPHENAZINE; HALOPERIDOL; HYOSCYAMINE; NORTRIPTYLINE; OLANZAPINE; OXYBUTYNIN; PAROXETINE; PIMOZIDE; QUETIAPINE; SEROTONIN 2A ANTAGONIST; SEROTONIN AGONIST; THIORIDAZINE; TOLTERODINE; UNINDEXED DRUG; ZIPRASIDONE;

AGITATED DELIRIUM; ANALGESIA; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; COMA; CRITICALLY ILL PATIENT; DELIRIUM; DEMENTIA; DRUG OVERDOSE; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; ENVIRONMENTAL FACTOR; EXTRAPYRAMIDAL SYMPTOM; GENERAL MEDICAL AIDS; HEARING IMPAIRMENT; HUMAN; HYPERACTIVITY; HYPERTHERMIA; HYPOTENSION; IMMOBILIZATION; INTENSIVE CARE; LIVER DISEASE; NEUROLEPTIC MALIGNANT SYNDROME; OCCUPATIONAL THERAPY; PERCEPTION DISORDER; PHYSIOTHERAPY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; QT PROLONGATION; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SCREENING; SEDATION; SEROTONIN SYNDROME; SLEEP WAKING CYCLE; URINE RETENTION; VISUAL ACUITY; VOMITING;

CRITICAL ILLNESS; DELIRIUM; EMERGENCIES; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PRESCRIPTION DRUG MISUSE; RISK ASSESSMENT; SEROTONIN SYNDROME; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84865450869     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31825ae0f8     Document Type: Review

References (131)

1. Krauseneck T, Graz C, Krähenmann O, et al: Psychiatric emergencies on ICU. Anasthesiol Intensivmed Notfallmed Schmerzther 2007; 42:10-13
2. Rizos DV, Peritogiannis V, Gkogkos C: Catatonia in the intensive care unit. Gen Hosp Psychiatry 2011; 33:e1-e2
3. Irani SR, Vincent A: Autoimmune encephalitis-new awareness, challenging questions. Discov Med 2011; 11:449-458
4. Neufeld K, Huberman A, Needham D: Delirium. In: Principles and Practice of Hospital Medicine. McKean S, Brotman D, Dressler D, et al (Eds). Illinois, Burr Ridge, McGraw-Hill, 2012, pp 548-558
5. Morandi A, Jackson JC, Ely EW: Delirium in the intensive care unit. Int Rev Psychiatry 2009; 21:43-58
6. Bergeron N, Dubois MJ, Dumont M, et al: Intensive Care Delirium Screening Checklist: Evaluation of a new screening tool. Intensive Care Med 2001; 27:859-864
7. Ely EW, Inouye SK, Bernard GR, et al: Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001; 286:2703-2710
8. Ely EW, Margolin R, Francis J, et al: Evaluation of delirium in critically ill patients: Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001; 29:1370-1379
9. Salluh JI, Soares M, Teles JM, et al; Delirium Epidemiology in Critical Care Study Group: Delirium epidemiology in critical care (DECCA): An international study. Crit Care 2010; 14:R210
10. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC, American Psychiatric Association, 1994
11. Ely EW, Truman B, Shintani A, et al: Monitoring sedation status over time in ICU patients: Reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003; 289:2983-2991
12. Peterson JF, Pun BT, Dittus RS, et al: Delirium and its motoric subtypes: A study of 614 critically ill patients. J Am Geriatr Soc 2006; 54:479-484
13. Pandharipande P, Cotton BA, Shintani A, et al: Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med 2007; 33:1726-1731
14. Wise MG: Delirium. In: Clinical Manual of Psychosomatic Medicine: A Guide to Consultation-Liason Psychiatry. Arlington, VA, American Psychiatric Publishing, 2005, pp 29-48
15. Ely EW, Shintani A, Truman B, et al: Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291:1753-1762
16. Lin SM, Liu CY, Wang CH, et al: The impact of delirium on the survival of mechanically ventilated patients. Crit Care Med 2004; 32:2254-2259
17. Ouimet S, Kavanagh BP, Gottfried SB, et al: Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 2007; 33:66-73
18. Pisani MA, Kong SY, Kasl SV, et al: Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009; 180:1092-1097
19. Shehabi Y, Riker RR, Bokesch PM, et al; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group: Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med 2010; 38:2311-2318
20. Thomason JW, Shintani A, Peterson JF, et al: Intensive care unit delirium is an independent predictor of longer hospital stay: A prospective analysis of 261 non-ventilated patients. Crit Care 2005; 9:R375-R381
21. Jackson JC, Gordon SM, Hart RP, et al: The association between delirium and cognitive decline: A review of the empirical literature. Neuropsychol Rev 2004; 14:87-98
22. Girard TD, Jackson JC, Pandharipande PP, et al: Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010; 38:1513-1520
23. van den Boogaard M, Schoonhoven L, Evers AWM, et al: Delirium in critically ill patients: Impact on long-term quality of life and cognitive functioning. Crit Care Med 2012; 40:112-118
24. Dubois MJ, Bergeron N, Dumont M, et al: Delirium in an intensive care unit: A study of risk factors. Intensive Care Med 2001; 27:1297-1304
25. Ely EW, Siegel MD, Inouye SK: Delirium in the intensive care unit: An under-recognized syndrome of organ dysfunction. Semin Respir Crit Care Med 2001; 22:115-126
26. Milbrandt EB, Deppen S, Harrison PL, et al: Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004; 32:955-962
27. Davydow DS, Desai SV, Needham DM, et al: Psychiatric morbidity in survivors of the acute respiratory distress syndrome: A systematic review. Psychosom Med 2008; 70:512-519
28. Davydow DS, Gifford JM, Desai SV, et al: Posttraumatic stress disorder in general intensive care unit survivors: A systematic review. Gen Hosp Psychiatry 2008; 30:421-434
29. Bienvenu OJ, Gould NF, Mason ST, et al: Anxiety disorders prevention: Overview and focus on post-traumatic stress disorder. Minerva Psichiatr 2009; 50:265-275
30. Bienvenu OJ, Neufeld KJ: Post-traumatic stress disorder in medical settings: Focus on the critically ill. Curr Psychiatry Rep 2011; 13:3-9
31. Davydow DS, Gifford JM, Desai SV, et al: Depression in general intensive care unit survivors: A systematic review. Intensive Care Med 2009; 35:796-809
32. Skirrow P, Jones C, Griffiths RD, et al: Intensive care: Easing the trauma. Psychologist 2001; 14:640-642
33. Sharshar T, Hopkinson NS, Orlikowski D, et al: Science review: The brain in sepsis-culprit and victim. Crit Care 2005; 9:37-44
34. Ebersoldt M, Sharshar T, Annane D: Sepsis-associated delirium. Intensive Care Med 2007; 33:941-950
35. Siami S, Annane D, Sharshar T: The encephalopathy in sepsis. Crit Care Clin 2008; 24:67-82, viii
36. Ekström-Jodal B, Häggendal J, Larsson LE, et al: Cerebral hemodynamics, oxygen uptake and cerebral arteriovenous differences of catecholamines following E. coli endotoxin in dogs. Acta Anaesthesiol Scand 1982; 26:446-452
37. Ekström-Jodal B, Larsson LE: Effects of dopamine of cerebral circulation and oxygen metabolism in endotoxic shock: An experimental study in dogs. Crit Care Med 1982; 10:375-377
38. Jackson JC, Hart RP, Gordon SM, et al: Post-traumatic stress disorder and post-traumatic stress symptoms following critical illness in medical intensive care unit patients: Assessing the magnitude of the problem. Crit Care 2007; 11:R27
39. Griffiths J, Fortune G, Barber V, et al: The prevalence of post traumatic stress disorder in survivors of ICU treatment: A systematic review. Intensive Care Med 2007; 33:1506-1518
40. Bienvenu OJ, Colantuoni E, Mendez-Tellez PA, et al: Depressive symptoms and impaired physical function after acute lung injury: A 2-year longitudinal study. Am J Respir Crit Care Med 2012; 185:517-524
41. Flacker JM, Lipsitz LA: Neural mechanisms of delirium: Current hypotheses and evolving concepts. J Gerontol A Biol Sci Med Sci 1999; 54:B239-B246
42. Steiner LA: Postoperative delirium. Part 1: Pathophysiology and risk factors. Eur J Anaesthesiol 2011; 28:628-636
43. Steiner LA: Postoperative delirium. part 2: Detection, prevention and treatment. Eur J Anaesthesiol 2011; 28:723-732
44. Jacobi J, Fraser GL, Coursin DB, et al; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119-141
45. Glassman AH, Bigger JT Jr: Antipsychotic drugs: Prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001; 158:1774-1782
46. Ayd FJ Jr: Haloperidol update: 1975. Proc R Soc Med 1976; 69(Suppl 1):14-22
47. Altamura AC, Sassella F, Santini A, et al: Intramuscular preparations of antipsychotics: Uses and relevance in clinical practice. Drugs 2003; 63:493-512
48. Skrobik YK, Bergeron N, Dumont M, et al: Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Med 2004; 30:444-449
49. Han CS, Kim YK: A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004; 45:297-301
50. Girard TD, Pandharipande PP, Carson SS, et al; MIND Trial Investigators: Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial. Crit Care Med 2010; 38:428-437
51. Devlin JW, Roberts RJ, Fong JJ, et al: Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38:419-427
52. Wan RY, Kasliwal M, McKenzie CA, et al: Quetiapine in refractory hyperactive and mixed intensive care delirium: A case series. Crit Care 2011; 15:R159
53. Reade MC, O'Sullivan K, Bates S, et al: Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: A randomised open-label trial. Crit Care 2009; 13:R75
54. Shehabi Y, Nakae H, Hammond N, et al: The effect of dexmedetomidine on agitation during weaning of mechanical ventilation in critically ill patients. Anaesth Intensive Care 2010; 38:82-90
55. Pandharipande P, Shintani A, Peterson J, et al: Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006; 104:21-26
56. Pandharipande PP, Pun BT, Herr DL, et al: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 2007; 298:2644-2653
57. Pandharipande P, Cotton BA, Shintani A, et al: Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008; 65:34-41
58. Riker RR, Shehabi Y, Bokesch PM, et al; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009; 301:489-499
59. Kollef MH, Levy NT, Ahrens TS, et al: The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998; 114:541-548
60. Weinert CR, Calvin AD: Epidemiology of sedation and sedation adequacy for mechanically ventilated patients in a medical and surgical intensive care unit. Crit Care Med 2007; 35:393-401
61. Payen JF, Chanques G, Mantz J, et al: Current practices in sedation and analgesia for mechanically ventilated critically ill patients: A prospective multicenter patient-based study. Anesthesiology 2007; 106:687-695
62. Arroliga AC, Thompson BT, Ancukiewicz M, et al; Acute Respiratory Distress Syndrome Network: Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med 2008; 36:1083-1088
63. Brook AD, Ahrens TS, Schaiff R, et al: Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27:2609-2615
64. Kress JP, Pohlman AS, O'Connor MF, et al: Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342:1471-1477
65. Girard TD, Kress JP, Fuchs BD, et al: Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): A randomised controlled trial. Lancet 2008; 371:126-134
66. Needham DM, Korupolu R, Zanni JM, et al: Early physical medicine and rehabilitation for patients with acute respiratory failure: A quality improvement project. Arch Phys Med Rehabil 2010; 91:536-542
67. Kress JP, Gehlbach B, Lacy M, et al: The long-term psychological effects of daily sedative interruption on critically ill patients. Am J Respir Crit Care Med 2003; 168:1457-1461
68. Jackson JC, Girard TD, Gordon SM, et al: Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial. Am J Respir Crit Care Med 2010; 182:183-191
69. Strøm T, Martinussen T, Toft P: A protocol of no sedation for critically ill patients receiving mechanical ventilation: A randomised trial. Lancet 2010; 375:475-480
70. Tune LE, Damlouji NF, Holland A, et al: Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet 1981; 2:651-653
71. Han L, McCusker J, Cole M, et al: Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001; 161:1099-1105
72. Flacker JM, Cummings V, Mach JR Jr, et al: The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry 1998; 6:31-41
73. Gerretsen P, Pollock BG: Drugs with anticholinergic properties: A current perspective on use and safety. Expert Opin Drug Saf 2011; 10:751-765
74. Chew ML, Mulsant BH, Pollock BG, et al: Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 2008; 56:1333-1341
75. Liptzin B, Laki A, Garb JL, et al: Donepezil in the prevention and treatment of post-surgical delirium. Am J Geriatr Psychiatry 2005; 13:1100-1106
76. Sampson EL, Raven PR, Ndhlovu PN, et al: A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. Int J Geriatr Psychiatry 2007; 22:343-349
77. Gamberini M, Bolliger D, Lurati Buse GA, et al: Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery-a randomized controlled trial. Crit Care Med 2009; 37:1762-1768
78. van Eijk MM, Roes KC, Honing ML, et al: Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: A multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010; 376:1829-1837
79. Novaes MA, Aronovich A, Ferraz MB, et al: Stressors in ICU: Patients' evaluation. Intensive Care Med 1997; 23:1282-1285
80. Nelson JE, Meier DE, Oei EJ, et al: Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 2001; 29:277-282
81. Morrison RS, Magaziner J, Gilbert M, et al: Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci 2003; 58:76-81
82. Eisendrath SJ, Goldman B, Douglas J, et al: Meperidine-induced delirium. Am J Psychiatry 1987; 144:1062-1065
83. Marcantonio ER, Juarez G, Goldman L, et al: The relationship of postoperative delirium with psychoactive medications. JAMA 1994; 272:1518-1522
84. Adunsky A, Levy R, Heim M, et al: Meperidine analgesia and delirium in aged hip fracture patients. Arch Gerontol Geriatr 2002; 35:253-259
85. Künig G, Dätwyler S, Eschen A, et al: Unrecognised long-lasting tramadol-induced delirium in two elderly patients. A case report. Pharmacopsychiatry 2006; 39:194-199
86. Brouquet A, Cudennec T, Benoist S, et al: Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery. Ann Surg 2010; 251:759-765
87. Kamdar BB, Needham DM, Collop NA: Sleep deprivation in critical illness: Its role in physical and psychological recovery. J Intensive Care Med 2012; 27:97-111
88. Helton MC, Gordon SH, Nunnery SL: The correlation between sleep deprivation and the intensive care unit syndrome. Heart Lung 1980; 9:464-468
89. Kahn DM, Cook TE, Carlisle CC, et al: Identification and modification of environmental noise in an ICU setting. Chest 1998; 114:535-540
90. Freedman NS, Kotzer N, Schwab RJ: Patient perception of sleep quality and etiology of sleep disruption in the intensive care unit. Am J Respir Crit Care Med 1999; 159(4 Pt 1):1155-1162
91. Topf M, Davis JE: Critical care unit noise and rapid eye movement (REM) sleep. Heart Lung 1993; 22:252-258
92. Freedman NS, Gazendam J, Levan L, et al: Abnormal sleep/wake cycles and the effect of environmental noise on sleep disruption in the intensive care unit. Am J Respir Crit Care Med 2001; 163:451-457
93. Gabor JY, Cooper AB, Crombach SA, et al: Contribution of the intensive care unit environment to sleep disruption in mechanically ventilated patients and healthy subjects. Am J Respir Crit Care Med 2003; 167:708-715
94. Elliott RM, McKinley SM, Eager D: A pilot study of sound levels in an Australian adult general intensive care unit. Noise Health 2010; 12:26-36
95. Olson DM, Borel CO, Laskowitz DT, et al: Quiet time: A nursing intervention to promote sleep in neurocritical care units. Am J Crit Care 2001; 10:74-78
96. Tamburri LM, DiBrienza R, Zozula R, et al: Nocturnal care interactions with patients in critical care units. Am J Crit Care 2004; 13:102-112
97. Bourne RS, Mills GH: Sleep disruption in critically ill patients-pharmacological considerations. Anaesthesia 2004; 59:374-384
98. Schweickert WD, Pohlman MC, Pohlman AS, et al: Early physical and occupational therapy in mechanically ventilated, critically ill patients: A randomised controlled trial. Lancet 2009; 373:1874-1882
99. Needham DM, Korupolu R: Rehabilitation quality improvement in an intensive care unit setting: Implementation of a quality improvement model. Top Stroke Rehabil 2010; 17:271-281
100. Inouye SK, Charpentier PA: Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996; 275:852-857
101. Inouye SK, Viscoli CM, Horwitz RI, et al: A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 1993; 119:474-481
102. Inouye SK: Predisposing and precipitating factors for delirium in hospitalized older patients. Dement Geriatr Cogn Disord 1999; 10:393-400
103. Inouye SK, Bogardus STJr, Charpentier PA, et al: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340:669-676
104. Marcantonio ER, Flacker JM, Wright RJ, et al: Reducing delirium after hip fracture: A randomized trial. J Am Geriatr Soc 2001; 49:516-522
105. Boyer EW, Shannon M: The serotonin syndrome. N Engl J Med 2005; 352:1112-1120
106. McAllen KJ, Schwartz DR: Adverse drug reactions resulting in hyperthermia in the intensive care unit. Crit Care Med 2010; 38(Suppl 6):S244-S252
107. Seitz DP, Gill SS: Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: Case reports and a review of the literature. Psychosomatics 2009; 50:8-15
108. Keck PEJr, Pope HGJr, Cohen BM, et al: Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry 1989; 46:914-918
109. Berardi D, Amore M, Keck PEJr, et al: Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: A case-control study. Biol Psychiatry 1998; 44:748-754
110. Sachdev P, Mason C, Hadzi-Pavlovic D: Case-control study of neuroleptic malignant syndrome. Am J Psychiatry 1997; 154:1156-1158
111. Viejo LF, Morales V, Puñal P, et al: Risk factors in neuroleptic malignant syndrome. A case-control study. Acta Psychiatr Scand 2003; 107:45-49
112. Bhanushali MJ, Tuite PJ: The evaluation and management of patients with neuroleptic malignant syndrome. Neurol Clin 2004; 22:389-411
113. Strawn JR, Keck PE Jr, Caroff SN: Neuroleptic malignant syndrome. Am J Psychiatry 2007; 164:870-876
114. Francis A, Chandragiri S, Rizvi S, et al: Is Lorazepam a treatment for neuroleptic malignant syndrome? CNS Spectr 2000; 5:54-57
115. Rosenberg MR, Green M: Neuroleptic malignant syndrome. Review of response to therapy. Arch Intern Med 1989; 149:1927-1931
116. Sakkas P, Davis JM, Janicak PG, et al: Drug treatment of the neuroleptic malignant syndrome. Psychopharmacol Bull 1991; 27:381-384
117. Trollor JN, Sachdev PS: Electroconvulsive treatment of neuroleptic malignant syndrome: A review and report of cases. Aust N Z J Psychiatry 1999; 33:650-659
118. Sternbach H: The serotonin syndrome. Am J Psychiatry 1991; 148:705-713
119. Gillman PK: The serotonin syndrome and its treatment. J Psychopharmacol (Oxford) 1999; 13:100-109
120. Sun-Edelstein C, Tepper SJ, Shapiro RE: Drug-induced serotonin syndrome: A review. Expert Opin Drug Saf 2008; 7:587-596
121. Dunkley EJ, Isbister GK, Sibbritt D, et al: The Hunter Serotonin Toxicity Criteria: Simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003; 96:635-642
122. Attar-Herzberg D, Apel A, Gang N, et al: The serotonin syndrome: Initial misdiagnosis. Isr Med Assoc J 2009; 11:367-370
123. Nisijima K, Shioda K, Yoshino T, et al: Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome. Neurochem Int 2003; 43:155-164
124. Hick JL, Smith SW, Lynch MT: Metabolic acidosis in restraint-associated cardiac arrest: A case series. Acad Emerg Med 1999; 6:239-243
125. Kapur S, Zipursky RB, Jones C, et al: Cyproheptadine: A potent in vivo serotonin antagonist. Am J Psychiatry 1997; 154:884
126. Snider SR, Hutt C, Stein B, et al: Increase in brain serotonin produced by bromocriptine. Neurosci Lett 1975; 1:237-241
127. Kline SS, Mauro LS, Scala-Barnett DM, et al: Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Clin Pharm 1989; 8:510-514
128. Henderson A, Wright M, Pond SM: Experience with 732 acute overdose patients admitted to an intensive care unit over six years. Med J Aust 1993; 158:28-30
129. Novack V, Jotkowitz A, Delgado J, et al: General characteristics of hospitalized patients after deliberate self-poisoning and risk factors for intensive care admission. Eur J Intern Med 2006; 17:485-489
130. Schatzberg AF, Haddad P, Kaplan EM, et al: Serotonin reuptake inhibitor discontinuation syndrome: A hypothetical definition. Discontinuation Consensus panel. J Clin Psychiatry 1997; 58(Suppl 7):5-10
131. Black K, Shea C, Dursun S, et al: Selective serotonin reuptake inhibitor discontinuation syndrome: Proposed diagnostic criteria. J Psychiatry Neurosci 2000; 25:255-261